Clinical Trial Update: Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating inhaled nitric oxide to prevent pulmonary hypertension after stored blood transfusion has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypertension, Pulmonary, Hemolysis | Phase 2 | Status: WITHDRAWN